Michelson Medical Research Foundation’s Arctos NorthStar Acquisition Corp. ANAC Stock Holding History

Michelson Medical Research Foundation’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-49,601	Closed	-$500K	–	30
2022 Q4	$500K	Buy	+49,601	New	+$496K	0.32%	30

Michelson Medical Research Foundation's ANAC Position: Q1 2023 in Review

Michelson Medical Research Foundation sold out of Arctos NorthStar Acquisition Corp. (ANAC) in Q1 2023, closing a stake of 49,601 shares — an estimated $500K sold.

Michelson Medical Research Foundation first reported a position in ANAC in Q4 2022 and held it in 1 quarter. The position peaked at $500K in Q4 2022. 0 funds tracked by Wall St. Rank hold ANAC as of Q1 2023.

Michelson Medical Research Foundation reported no remaining Arctos NorthStar Acquisition Corp. position as of Q1 2023 after selling out during the quarter.
Michelson Medical Research Foundation sold 49,601 Arctos NorthStar Acquisition Corp. shares in Q1 2023, an estimated $500K.
Michelson Medical Research Foundation first reported a position in Arctos NorthStar Acquisition Corp. in Q4 2022 and held it in 1 quarter.
Michelson Medical Research Foundation's Arctos NorthStar Acquisition Corp. position peaked at $500K in Q4 2022.
0 funds tracked by Wall St. Rank held Arctos NorthStar Acquisition Corp. as of Q1 2023.

Based on Michelson Medical Research Foundation's 13F filing for Q1 2023, filed 15 May 2023.